Patients who received an MRA dose of ≥12.5 mg/d (ie, any doses of MRA) after TEER had less severe anemia, higher glomerular filtration rate, and lower plasma BNP levels, although the absolute differences in these values were clinically trivial. Here, NPPB is linked to anemia (phenotype).